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 ABBREVIATIONS 
 
AR = aortic regurgitation 
AV = aortic valve 
AVR = aortic valve replacement 
AVRep = aortic valve repair 
LV = left ventricle 
LVOT = left ventricle outflow tract 
STJ = sinotubular junction 
VAJ = ventriculo-aortic junction 
RA = right atrium 
FAA = functional aortic annulus 
BAV = bicuspid aortic valve 
LVEF = left ventricular ejection fraction 
LVEDD = left ventricular end-diastolic diameter 
LVESD = left ventricular end-systolic diameter 
TTE = transthoracic echocardiography 
TEE = transesophageal echocardiography 
VSRR = valve-sparing aortic root replacement 
VSD = ventricular septal defect 
NYHA = New York Heart Association 
EuroSCORE = European System for Cardiac Operative Risk Evaluation  
IQR = interquartile range 
MV = mitral valve 
MVRep = mitral valve repair 
CABG = coronary artery by-pass grafting 
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Chronic aortic regurgitation (AR) sets in motion numerous compensatory 
mechanisms for left ventricle (LV) to be able to maintain normal ejection 
fraction (EF), regardless of chronic volume and pressure overload. With long 
standing AR compensatory mechanism eventually fail and EF decreases. The 
survival prognosis is poor once symptoms develop. That is why current 
guidelines recommend surgical intervention in case of symptoms, EF≤50% or 
left ventricular end-diastolic diameter (LVEDD) > 70mm or left ventricular end-
systolic diameter (LVESD) > 50mm.  
Aortic valve replacement (AVR) is an established treatment for patients with 
AR. In the past 20 years numerous repair techniques for diseased aortic 
valves (AV) have been developed with the aim to be able to treat AR without 
subjecting patient to possible complications connected with mechanical or 
bioprosthetic valve implantation. Promising results of aortic valve repair 
(AVRep) surgeries in terms of overall survival, freedom from re-operation and 
valve related complications have been documented.  
LV reverse remodeling has been reported both after AVR and AVRep. This 
retrospective study investigated and compared changes in LV dimension 
(LVEDD) and function (LVEF) between 32 patients who underwent AVR and 
25 who underwent AVRep for treatment of AR.  Statistically significant 
(p<0,05) decrease of LVEDD has been documented in both groups when 
comparing dimensions immediately post-operatively and at early follow-up 
with dimensions measured pre-operatively. LVEF has decreased immediately 
post-operatively but normalized at early follow-up in both groups. This proves 
that both AVR and AVRep lead to LV reverse remodeling with comparable 
LVEDD and LVEF immediately post-operatively and at early follow-up.
INTRODUCTION 
 
Aortic regurgitation (AR) is a consequence of either aortic valve (AV) disease 
or dilation of aortic root. It has been traditionally treated with aortic valve 
replacement (AVR) surgery. Attempts at aortic valve repair (AVRep) began 
already in the 1950s but due to poor success and later wide availability of 
mechanical and biological valve prostheses the AVRep was nearly 
abandoned[1]. The interest in developing and improving AVRep techniques 
decreased for a while until the 1980s when Carpentier’s success [2] on mitral 
valve repair renewed the interest in AVRep operations. AVRep is an attractive 
treatment alternative to AVR because it avoids long-term risks associated with 
prosthetic valve implantation. A major drawback of biological valves is limited 
durability of the prostheses. Mechanical valves are connected to cumulative 
incidence of valve-related complications, including thromboembolism and 
hemorrhage, ranging from 4-5% per year[3]. Both are connected with 
increased overall risk of endocarditis.  
The quality of life of young patients after surgery seems to be affected by the 
type of operation and it was shown that AVRep is connected with lower 
degree of worrying about possible valve failure as opposed to AVR[4].  
The AV separates the left ventricle (LV) from systemic circulation. It lies at the 
terminal portion of left ventricular outflow tract (LVOT). The normal working of 
this tricuspid semilunar apparatus is critical for maintenance of efficient 
cardiac function.  
The leaflets of the AV are supported and surrounded by the structures that 
together form the functional and anatomic unit the so-called aortic root (Figure 
1). The components of the aortic root are: annulus, leaflets, leaflet 
attachments, aortic sinuses (Sinuses of Valsava), interleaflet triangles and 
sinotubular junction (STJ)[5]. The aortic root extends from the basal 
attachments of the leaflets within the LV to the STJ.  
Normally, an AV is composed of three leaflets. They are attached in a 
semilunar fashion within the valvar sinuses. Together, these attachments form 
a thick fibrous crown-shaped structure, often termed “annulus”. This 
description is unfortunate because annulus implies a circular structure, which  
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Figure 1: Aortic root anatomy (schematic representation);
adapted from Anderson RH [6]
 
leaflet attachments do not form. This crown-shaped structure formed by leaflet 
attachments is also frequently called ventriculo-aortic junction (VAJ). This 
term is rather unclear since the anatomical ventriculo-aortic junction, found at 
the point where the ventricular structures change into fibroelastic wall of the 
arterial trunk, is a distinct circular locus within the aortic root and is not 
coincident with the leaflet attachments[6]. For the purpose of this study, both 
terms VAJ and annulus will be used to describe the crown-shaped structure 
formed by leaflet attachments at the base of aortic root. 
The leaflets form a hemodynamic junction between LV and aorta. Everything 
distal to them is subjected to arterial pressures and all the structures proximal 
to their attachments are subjected to ventricular pressures. Physiologic 
trileaflet structure of the AV is the optimal solution for a low resistance valve 
opening[5]. The AV must open and close with minimal pressure differences 
between the ventricle and aorta. During closure, it must prevent the backflow 
of the blood. In order for that to happen, the leaflets must be perfectly aligned 
and should have a homogeneous coaptation line. 
During the ventricular systole, the semilunar leaflets open into aortic sinuses 
called sinuses of Valsava. Two of those sinuses give rise to coronary arteries 
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consequently naming sinuses as the right and left coronary sinus and non-
coronary or posterior sinus. Most of the sinuses’ walls are made of thinned 
aortic wall but at their bases, the ventricular musculature is partly 
incorporated. This is not true for the base of the non-coronary sinus, which is 
made of fibrous tissue due to the continuity of leaflets of aortic and mitral 
valves.  
The areas where the attachments of two adjacent AV cusps meet 
compromise commissures. Under each commissure lies one of the three 
interleaflet triangles. These represent the extension of LVOT but rather than 
being bound by ventricular musculature, histologically they are made of 
thinned aortic wall[7]. These triangles are the crucial part of proper valvar 
function since through them, the systolic expansion of aortic root maximizes 
ejection of LV and reduces shear stress on the cusps[8]. The triangle between 
non-coronary and right coronary sinuses faces the right atrium (RA). It is 
incorporated within the membranous part of the septum. During surgery this 
area is of special importance because of the proximity of His bundle and any 
injury of this bundle can lead to temporary or permanent conduction 
abnormalities. The triangle between the non-coronary and left coronary 
sinuses is positioned along the aortic valve-mitral valve continuity. The fibrous 
aortomitral curtain lies beneath this triangle[5]. The triangle between the right 
and left coronary sinuses faces the commissure of the pulmonary valve.  
STJ separates the aortic root from the ascending aorta. It supports the 
peripheral attachments of the leaflets. Together with the ventriculo-aortic 
junction (VAJ), it forms functional aortic annulus (FAA)[9].  
Failure of coaptation of valve leaflets during diastole leads to AR. This can be 
the consequence of distorted valve leaflets, dilated aortic annulus or 
combination of both. Most common pathologies leading to distorted leaflets 
are rheumatic disease, infective endocarditis, bicuspid aortic valve (BAV), 
calcific aortic disease, idiopathic degenerative disease and myxomatous 
proliferation of aortic tissue. Pathologies that lead to aortic annular dilatation 
and consequently to improper valvular closure are aortic dissection, trauma, 
connective tissue disorders such as Marfan syndrome, degenerative disease, 
aortitis (syphilitic, noninfectious giant cell). 
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Pathophysiological consequences of AR depend on the duration of the 
process. Acute AR is defined as hemodinamically significant aortic 
incompetence of sudden onset across previously competent AV in LV 
previously not subjected to volume overload. Common etiologies leading to 
acute AR are endocarditis, aortic dissection and trauma. Due to acute onset, 
the LV is unable to adapt to increased end-diastolic pressure. Hence, effective 
cardiac output is smaller as in chronic AR. In order to compensate for low 
cardiac output, the heart rate increases.  
On the other hand, chronic AR causes gradual LV volume overload. This 
leads to numerous compensatory changes, including LV eccentric 
hypertrophy and enlargement. Due to this ventricular remodeling, patients 
may remain asymptomatic for a significant amount of time[10]. Nevertheless, 
with the progression of AR, the compensatory mechanisms fail and the patient 
becomes symptomatic. After the development of symptoms, the long-term 
prognosis is poor. In order to prevent further deterioration and possible 
development of heart failure, current guidelines recommend surgical 
intervention of all symptomatic patients with AR. Surgical intervention is also 
recommended for all asymptomatic patients with AR with impaired LV function 
(LVEF≤50%) or LVEDD>70mm or LVESD>50mm since there is increased risk 
of developing irreversible myocardial dysfunction[11].  
Echocardiography is the diagnostic method of choice when evaluating 
patients with AR. Either transthoracic echocardiography (TTE) or more 
invasive transesophageal echocardiography (TEE) can be used for the 
evaluation of AR severity and hemodynamic consequences, delineation of 
underlying mechanism(s) and to predict its reparability. The image quality 
produced by TTE is frequently insufficient for reliable assessment of 
underlying AR mechanism(s). TEE is therefore the preferred method for 
evaluating the mechanism of AR[12]. During preoperative assessment of AR 
by either TTE or TEE it is important to measure the size of aortic annulus, 
sinuses of Valsava, STJ and the first centimeters of ascending aorta (Figure 
2). These measurements are best done in end-diastole. At the same time, one 
can also measure the length of cusp apposition and the cusp effective height. 
Effective height (Figure 3) is the height difference between central free 
margins of the leaflets and the aortic insertion lines. In adults, it normally 
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measures 9-10mm and everything less than 6-7mm indicates a degree of 
prolapse[13]. Any structural deformity of the leaflets as well as number of 
leaflets should be noted. Intraoperative TEE is mandatory during AVRep 
procedures as it represents a great tool for the assessment of repair 
adequacy and prediction of recurrent AR[12]. Whether or not the patient is a 
candidate for surgery depends on symptoms and LV dimension and function 
measurements done during echocardiography[11].   
 
 
 
Figure 2: Measurements of the aortic diameters. 1: annulus; 2: sinuses of 
Valsava; 3: sinotubular junction; 4: proximal ascending aorta[14]. 
 
 
 
 
Figure 3: Effective height (eH). Schematic drawing of aortic valve and root. 
AN: annulus; LH: leaflet height; STJ: sinotubular junction[13]. 
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Back in 1983, Carpentier wrote that surgeons are not basically concerned with 
the lesion but rather care more about the function. He defined the aim of the 
valve reconstruction as restoration of normal valve function and developed a 
functional approach to dealing with valve lesions with the goal of simplification 
of valve analysis before operation. He classified the valve lesions into type I 
(normal leaflet motion), type II (prolapsed leaflet) and type III (restricted leaflet 
motion)[2]. 
This guided development of repair oriented functional classification of AR 
(Figure 4) with the aim to provide a common framework for AV assessment 
and to guide approach to valve repair. Before describing functional 
classification, one must remember that the annulus of aortic valve is not a 
single anatomic structure as is annulus of the mitral valve, but rather consists 
of two separate components, VAJ and STJ, which together form the so called 
FAA. 
Any lesion of FAA with normal leaflet motion is considered as type I AR. This 
group is further subdivided into type Ia-d AR. Type Ia AR results from STJ 
enlargement and dilatation of ascending aorta, type Ib AR results from 
dilatation of the sinuses of the Valsava and the STJ, type Ic results from the 
dilatation of VAJ and type Id results from cusp perforation without primary  
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Figure 4: Repair-oriented functional classification of aortic regurgitation[15] 
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FAA lesion. As type II AR are considered all those lesions resulting in leaflet 
prolapse either due to excessive leaflet tissue or commissural disruption. 
Type III AR is characterized by restrictive leaflet motion, which can be the 
consequence of bicuspid, degenerative or rheumatic valvular disease. One 
must have in mind that patients may have single or multiple lesions 
contributing to AR, for example patients with type Ib lesions may present with 
concomitant cusp prolapse (type II) which must be carefully evaluated during 
surgery[15].  
After thorough pre-operative echocardiographic evaluation and determination 
of underlying mechanism of AR, the surgeon is able to choose the most 
appropriate surgical technique that would restore normal valve physiology. 
Even though the AVR has been standard surgical procedure for treatment of 
AR for many years, a great improvement has been done in understanding the 
normal anatomy of AV as well as interrelation between AV and aortic root and 
appreciation of different mechanisms leading to AR. These important 
improvements have lead to AVRep operations becoming a more and more 
attractive alternative to AVR surgeries. The term AVRep does not only imply 
the repair of the cusps but also includes valve-sparing root replacement or 
any kind of FAA stabilization.  
As mentioned above, the possible underlying mechanisms leading to AR are 
classified into type I, II or III AR. This classification helps the surgeon to 
choose an appropriate repair technique. The goal of cusp prolapse correction 
is the elimination of redundant tissue at the level of free margin and re-
establishment of homogenous coaptation line for all leaflets. This is most 
commonly done by plicating sutures (5-0 or 6-0 polypropylene) in the central 
part of the free cusp margin. Any presence of cusp fenestration together with 
cusp prolapse should be properly addressed and closure of these 
fenestrations with an autologous pericardial patch has lead to good long-term 
results[16]. Effective height of the cusps should be measured after correction 
of the prolapse in order to objectively assess the repair and avoid potential 
failure of procedure.  
In restrictive leaflet disease, shaving or decalcification is required with or 
without patching. The outcome of these procedures has been poor and type 
III lesions represent risk factor for recurrent AR[15]. 
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When performing isolated AV repair, one should keep in mind the fact that 
any dilatation of the annulus is a risk factor for failure of the procedure. 
Different techniques have been proposed over the years to address this 
problem.  The biggest experience has been obtained by expansible external 
device placed at the level of VAJ[17]. 
Valve-sparing aortic root replacement (VSRR) techniques are widely accepted 
treatment methods when AR is a consequence of dilated FAA and leaflet 
motion is otherwise normal. Two types of VSRR operations were originally 
performed to treat dilated FAA: aortic root remodeling[18] and aortic valve 
reimplantation[19].  
For both techniques, the best exposure is median sternotomy. After cross-
clamping and longitudinal opening of the ascending aorta the aortic root is 
transected above the commissures. The aneurysmal aortic sinuses are 
excised, leaving 5mm of aortic wall adjacent to cusp insertion lines and 
around coronary artery orifices.  
When performing aortic root remodeling, the next step should include gentle 
stretching of the three commissures in the vertical direction by means of three 
horizontal mattress sutures placed just above the top of each commissure and 
approximation until the cusps coapt. The appropriate size of the graft is 
chosen and tailored to create three neo-aortic sinuses. The commissures are 
suspended in the graft that is sutured to the cusp insertion lines and remnants 
of aortic wall tissue. 
If valve reimplantation is planned the excision of aortic sinuses (as in 
remodeling technique) is followed by placing multiple horizontal mattress 
sutures just below the nadir of aortic annulus. They are passed from the 
inside to the outside of LVOT. The appropriate size of the graft is chosen and 
a small triangle may be cut out in order to accommodate the septal muscle 
below the commissure between left and right cups. The prepared sutures are 
passed through the graft and tied on the outside. The three commissures are 
suspended inside the graft and before the remnants of the aortic wall can be 
sutured to the graft one must carefully inspect the commissures and cusps to 
make sure they are all correctly aligned[20]. 
A crucial component of either aortic root remodeling or aortic valve 
reimplantation technique is assessment and repair-if necessary-of the AV. 
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Any residual cusp prolapse has been linked to increased risk of early failure of 
the aortic valve sparing procedure and the need for re-operation[21]. The best 
approach to intra-operative evaluation of any residual prolapse has been 
shown to be the objective measurement of effective height using a cusp 
caliper (Figure 5) [22].  
 
 
Figure 5: Resuspension of cusp effective height using a caliper as described 
by Schäfers et al.[23] 
 
 
Both original VSRR procedures, which are described above, have undergone 
many modifications and improvements throughout the years. It was 
recognized that both have certain advantages and disadvantages. Studies 
have shown that the remodeling procedure provides more physiologic cusp 
motion and flow patterns but at the same time fails to address the annular 
dilation. The reimplantation technique, on the other hand, addresses the 
annular dilation but impairs the aortic root dynamics because it withdraws the 
sinuses of Valsava and includes the interleaflet triangles within the graft 
tube[24]. Numerous variations of both techniques have been proposed with 
the aim of preserving normal aortic root dynamics and simultaneously treating 
dilated annulus[25]. The widespread use of these modifications has been 
limited. Taking this into consideration, Lansac proposed a standardized 
approach to aortic valve repair associating physiologic remodeling of the root 
with resuspension of cusp effective height and subvalvular aortic annuloplasty 
with an external expansible ring (Figure 6). This ring was designed in order to 
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increase cusps coaptation height, reduce stress on the cusps and protect the 
repair[23].  
 
 
 
 
Figure 6: Standardized approach to aortic valve repair as proposed by Lansac 
(C), combining advantages of aortic root remodeling (A) and aortic valve 
reimplantation (B) [23]. 
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AIM OF THE STUDY 
 
Chronic AR sets numerous compensatory mechanisms in motion to 
accommodate for volume and pressure overload caused by regurgitating 
valve. LV eccentric hypertrophy with consecutive increase in LV dimensions 
happens in order for LV to be able to maintain normal left ventricular ejection 
fraction (LVEF). These adaptive mechanisms allow for relatively 
asymptomatic course of the disease. Over time the adaptive mechanisms fail 
and symptoms occur. Patients with severe LV dilatation and symptoms have 
poor survival if not treated appropriately.  
Surgical intervention is recommended for all symptomatic patients or for 
asymptomatic patients with severely impaired LV function (LVEF≤50%, 
LVEDD>70mm or LVESD>50mm)[11].   
The aim of this study was to evaluate changes in LV dimensions and function 
after AVR and AVRep and to prove that AVRep is just as suitable therapeutic 
option for AR with satisfactory postoperative outcomes in terms of left 
ventricular end-diastolic diameter (LVEDD) and LVEF when compared to 
AVR.  
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PATIENTS AND METHODS 
 
This is a retrospective review of patients who underwent AVR or AVRep due 
to AR with or without aortic root aneurysm at the University Hospital Dubrava 
in Zagreb. 
 
Study population 
Between January 2013 and February 2016, 57 patients underwent surgery for 
treatment of AR that was either isolated or associated with aortic root dilation. 
Baseline demographic and clinical characteristics were collected before 
surgery and are summarized in Table 1.  
The mean patient age was 53±13,7 years. There were 47 (82%) male patients 
and 10 (18%) female patients.  
There were 22 (39%) patients altogether with bicuspid aortic valve (BAV), 1 
was suffering from Marfan syndrome and 4 (7%) patients developed AR as a 
consequence of endocarditis. 1 patient had AR associated with ventricular 
septal defect (VSD). 
All patients were classified pre-operatively according to New York Heart 
association (NYHA) functional classification for heart failure. There were 10 
(18%) patients in NYHA class I, 43 (75%) patients in NYHA class II, 4 (7%) 
patients in NYHA class III and none of the patients had NYHA class IV score.  
Predictive operative mortality was calculated according to European System 
for Cardiac Operative Risk Evaluation scoring system (EuroSCORE and 
EuroSCORE II). Mean logistic EuroSCORE was 5,84±0,03% and mean 
EuroSCORE II was 2,95±0,02%.  
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Table 1: Baseline clinical characteristics 
 
 AVR (n=32) AVRep (n=25) P value 
Age 55±13,02 50±14,3 0,19 
Female 6 (19) 4 (16) 0,79 
Male 26 (81) 21 (84) 0,79 
NYHA functional 
class 
   
I 4 (13) 6 (24) 0,4 
II 25 (78) 18 (72) 0,4 
III 3 (9) 1 (4) 0,4 
IV 0 0  
EuroSCORE  5,75±0,03% 5,94±0,02% 0,81 
EuroSCORE II 2,82±0,02% 3,13±0,02% 0,5 
Bicuspid aortic valve 11 (34) 11 (44) 0,5 
Marfan syndrome 0 1 (6)  
VSD 1 (3) 0  
Endocarditis 
 
3 (9) 1 (4) 0,4 
 
All data are presented as mean ± standard deviation or as number 
(percentage).  
AVR: aortic valve replacement; AVRep: Aortic valve repair; NYHA: New York 
Heart Association; EuroSCORE: European System for Cardiac Operative Risk 
Evaluation; VSD: ventricular septal defect 
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Echocardiography 
All patients underwent pre-operative transthoracic echocardiography (TTE) for 
assessment of AV anatomy and aortic root diameters (annulus, sinuses of 
Valsava, STJ and proximal ascending aorta) as well as dimensions and 
function of LV. M-mode and 2-dimensional echocardiography, as well as 
conventional and color Doppler data were acquired. Enlarged LVEDD was 
defined for values above 57mm. Impaired LVEF was defined for all values 
below 50%.  
Mean pre-operative LVEF was 58,7 ± 9,9 % and mean pre-operative LVEDD 
was 62,2 ± 8,9 mm. 
AR severity was assessed using a multiparametric approach that includes 
measurement of the jet width relative to the LV outflow tract width, vena 
contracta width and magnitude of the diastolic flow reversal in descending 
aorta when assessable according to current recommendations[14]. AR was 
classified as zero (grade 0), trivial (grade 1+), mild (grade 2+), moderate 
(grade 3+) and severe (grade 4+). Table 2 summarizes pre-operative AR 
grades. 
Transesophageal echocardiography (TEE) was performed intraoperatively 
both before and after AVRep or AVR.  
 
Table 2: Pre-operative aortic regurgitation grades 
 
Aortic regurgitation 
grade 
AVR AVRep P value 
     Trivial 1 (3) 1 (4) 0,3 
     Mild 2 (6) 6 (24) 0,3 
     Moderate 13 (41) 9 (36) 0,3 
     Severe 16 (50) 9 (36) 0,3 
 
All data are presented as number (percentage).  
AVR: aortic valve replacement; AVRep: aortic valve repair 
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Surgery 
Attending surgeon together with cardiologist who evaluated the patient pre-
operatively made the choice of most appropriate surgical technique.  
AVR was performed in 32 (56%) patients. 10 (31%) patients underwent 
isolated replacement of AV and 22 patients (69%) had both AV and ascending 
aorta replaced. 21 (66%) mechanical valves and 11 (34%) bioprosthetic 
valves were implanted.  
25 (44%) patients underwent AVRep. Most commonly performed AVRep 
technique was the one as described by Lansac (23 patients) [23]. There was 
1 patient who underwent isolated valve repair with subvalvular aortic 
annuloplasty with external expansible ring and in 1 patient annular 
stabilization was done by subcommissural annuloplasty[26] rather than by 
subvalvular annuloplasty with external expansible ring. Effective height of 
each cusp was measured using a caliper in order to evaluate any residual or 
induced cusp prolapse during AVRep procedure.  
 
Follow-up 
Echocardiography was performed during the immediate post-operative period 
(within 7 days from operation) by the cardiologists working at the University 
Hospital Dubrava and at early follow up (within 6 months from operation) 
appointments by the cardiologists that were individually chosen by the patient. 
LVEDD and LVEF were measured and measures were compared to those 
obtained at the pre-operative echocardiographic evaluation.  
Median echocardiographic follow up time was 6 months (IQR= 4 to 9 months). 
All patients were still alive at the time when this paper was written.  
 
Statistical Analysis 
Continuous variables are presented as mean ± standard deviation or median 
with interquartile ranges (IQR). Categorical variables are reported as counts 
and percentages. Independent and paired student’s t-tests were used for 
comparison of continuous variables when appropriate. Categorical variables 
were analyzed using χ2 test.  
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All statistical analyses were performed using SPSS version 24.0 software.  
Values of p<0,05 were considered statistically significant.  
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RESULTS 
 
Preoperative and operative data 
Preoperative clinical characteristics of patients undergoing either AVR or 
AVRep were comparable (Table 1). The mean age at operation was similar 
between the two groups (AVR=55±13,02 vs AVRep=50±14,3, p=0,19) as well 
as proportion of male and female patients (6 females and 26 males in AVR 
group and 4 females and 21 males in AVRep group, p=0,79). There was also 
a comparable proportion of BAV among patients treated by AVR or AVRep 
(34% vs 44%, p=0,5).  
No significant difference comparing predictive operative mortality calculated 
by EuroSCORE and EuroSCORE II (EuroSCORE: AVR=5,75±0,03% vs 
AVRep=5,94±0,02%, p=0,81. EuroSCORE II: AVR=2,82±0,02% vs 
AVRep=3,13±0,02%, p=0,5) scoring systems was noticed. 
More patients with AR as a consequence of endocarditis were in AVR group 
(3 patients) compared to AVRep group (1 patient). 1 patient in AVRep group 
had AR as a consequence of Marfan syndrome.  
Table 3 summarizes operative data. No patients died in the operative room. 
There were 2 patients who first underwent AVRep procedure but were re-
operated due to poor echocardiographic results during immediate post-
operative period and replacement of aortic valve together with aortic arch 
replacement was done.  
The difference between cross clamp and pump times among groups was 
significant (Cross clamp time: AVR=80±31 vs AVRep=120,2±27,1, p<0,05. 
Pump time: AVR=117,8±42,1 vs AVRep=154,1±27,1, p<0,05).  
2 (8%) patients in AVRep group had concomitant coronary artery by-pass 
grafting done and 1 (4%) patient had mitral valve (MV) repaired in addition to 
AVRep. There was 1 patient who underwent VSD closure together with AVR.  
Altogether 45 patients had concomitant aortic arch replacement, 22 (69%) in 
AVR group and 23 (92%) in AVRep group (p=0,01). 1 patient in AVRep group 
had aortic hemi-arch replacement done.  
There were 17 (68%) patients in AVRep group who required additional cusp 
repair (plication of the free edge of the leaflet, fenestration closure).  
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Table 3: Operative data 
 
 AVR (n=32) AVRep (n=25) P value 
Cross clamp time, 
min 
80±31 120,2±27,1 <0,05 
Pump time, min 117,8±42,1 154,1±27,1 <0,05 
Type of valve    
     Mechanical 21 (66)   
     Bioprosthetic 11 (34)   
Associated surgical 
procedures 
   
     CABG  2 (8)  
     Ascending aorta    
replacement 
22 (69) 23 (92) 0,01 
     Hemiarch   1 (4)  
     MVRep  1 (4)  
     VSD closure 1 (3)   
Additional aortic 
cusp repair 
 17 (68)  
 
All data are presented as mean ± standard deviation or as number 
(percentage). 
AVR: aortic valve replacement; AVRep: Aortic valve repair; CABG: coronary 
artery by-pass grafting; MVRep: Mitral Valve repair; VSD: Ventricular Septal 
Defect 
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Echocardiography  
Complete echocardiographic follow up data could be obtained in all but 15 
patients (7 in AVR group and 8 in AVRep group).  
Figure 7 shows how AR severity grade changed over time. AR severity 
grades were comparable among groups both pre-operatively and post-
operatively (p=0,3 for both). There was 1 patient in AVRep group who had 
mild AR during immediate post-operative period, all other patients left the 
hospital with zero to trivial AR. During follow up period AR grade in AVR 
group remained zero to trivial for all patients, whereas in AVRep group 5 
additional patients had mild AR.  
Table 4 summarizes echocardiographic parameters as measured pre-
operatively, immediately post-operatively and at follow up appointments. Both 
pre-operative LVEDD and LVEF were comparable between groups. Mean 
pre-operative LVEDD in AVR was 62,6±8,7 mm and in AVRep group 61,6±9,3 
mm (p=0,7). In both groups we can notice a significant decrease in post-
operative LVEDD in comparison to pre-operative LVEDD (AVR=58,2±7,4mm 
vs AVRep=56,5±9,2mm, p=0,4). LVEDD further decreased at early follow-up 
(AVR=53,5±5,4mm vs AVRep=52,9±4,8mm, p=0,7).  
LVEF decreased in both groups immediately post-operatively, which can be 
explained by acute correction of volume overload. However, at early follow-up 
LVEF normalized (AVR=59,4±7,8% vs AVRep=63,1±7,5%, p=0,1) in both 
groups.  
Figure 8 illustrates how LVEDD and LVEF changed over time in both groups.  
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Table 4: Echocardiographic data 
 
 AVR (n=32) AVRep (n=25) P value 
LVEDD (mm)    
     Pre-operative 62,6±8,7 61,6±9,3  0,7 
     Post-operative 58,2±7,4* 56,5±9,2* 0,4 
     Follow up 53,5±5,4*,† 52,9±4,8* 0,7 
LVEF (%)    
     Pre-operative 56,9±9,3 61±10,4 0,1 
     Post-operative 53,6±10,8* 57,2±10,1* 0,2 
     Follow up 59,4±7,8*,† 63,1±7,5 0,1 
 
All data are presented as mean ± standard deviation.  
AVR: aortic valve replacement; AVRep: aortic valve repair; LVEDD: left 
ventricular end-diastolic diameter; LVEF: Left ventricular ejection fraction 
Within groups: 
*p<0,05 versus pre-operative 
†p<0,05 versus post-operative 
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Figure 7: Aortic regurgitation severity grades over time. Data are displayed as 
percentages per group. AVR: aortic valve replacement; AVRep: aortic valve 
repair 
 21
 
 
Figure 8: Left ventricular end-dastolic diameter and left ventricular ejection 
fraction over time in aortic valve replacement compared to aortic valve repair. 
Data are displayed as estimated means. LVEDD: left ventricular end-diastolic 
volume; LVEF: left ventricular ejection fraction; AVR: aortic valve 
replacement; AVRep: aortic valve repair. 
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DISCUSSION 
 
This study was performed to compare the effects of AVRep versus AVR 
operations on LV dimensions and function immediately post-operatively and 
at early follow up. Immediately post-operatively a significant decrease in 
LVEDD has been noted in AVRep group as well as in AVR group with further 
decrease at early follow-up. LVEF was lower in both groups immediately post-
operatively in comparison to pre-operatively but normalized at early follow up.  
There is no doubt that AVRep techniques are an attractive alternative to AVR 
surgery in order to avoid risks of prosthetic valve such as thromboembolism, 
structural deterioration, endocarditis and hemorrhagic events connected to 
long-term anticoagulation therapy.  
One could argue the decision of sparing the AV leaflets that have suffered 
from years of chronic AR instead of replacing the valve with either mechanical 
or biologic prosthesis, since there is a possibility of failing to restore the 
normal competence of AV and thus failing to remove the volume overload on 
LV. 
Recent improvements in understanding functional anatomy of aortic root and 
physiology of aortic valve with appreciation of importance of adjacent 
structures have lead to favorable outcomes of valve sparing aortic root 
replacement techniques with or without AV repair in terms of overall survival, 
freedom from reoperation and freedom from AR grade>2 at follow up[27][28]. 
Risk factors leading to potential failure of valve preserving procedures have 
been identified and techniques to correct those possible factors leading to 
failure of valve sparing operations have been proposed and applied with 
favorable outcomes[21][29]. With further experience the repair techniques 
have been successfully applied even in patients with BAV[30].  
Comparison of AVR and AVRep techniques has led to the conclusion that 
both lead to similar survival rates but AVRep is connected to lower rates of 
valve-related complications, such as thromboembolism, bleeding and 
endocarditis[31][32].  
Even though the above-mentioned studies show satisfying results after 
AVRep operations, the lack of technical standardization of the AVRep 
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techniques limits their widespread use and reproducibility. Taking this into 
consideration, Lansac et al. proposed the before-mentioned standardized 
approach to AV repair with the aim of defining the actual best surgical strategy 
when it comes to treatment of aortic root aneurysm with or without AV 
disease. 
AR imposes a volume overload on heart, which responds to it by LV 
remodeling. Chronic long standing AR is relatively well compensated by LV 
remodeling and can be well tolerated for a significant amount of time. 
However, if left untreated, the compensating mechanism eventually fails and 
LVEF decreases. Patients become symptomatic and have poor survival if 
remaining under medical treatment only. Several studies have shown 
changes in LV dimensions and function after AVR operations for treatment of 
AR. Already back in 1978, a study made by Gaasch et al.[33] reported of 
postoperative LVEDD decrease after AVR.   Tanoue et al.[34] showed that LV 
contractility increased in 93 patients who underwent AVR as treatment for AR. 
They have also noticed change in LVEDD and LVEF. LVEDD changed from 
64.3±9.2mm pre-operatively to 52.3±9.9mm directly post-operatively and to 
48.4±9.0mm at 1-year follow up. LVEF showed decrease from pre-operatively 
60.2±11.0% to post-operatively 51.9±14.6% but later stabilization at 1-year 
follow up to 57.9±15.2%. Cho SH et al.[35] also observed similar changes in 
terms of LVEF and LVEDD.  
A few studies have described changes in LV function and volumes after 
AVRep procedures[36][37]. A. Mangini et al. [37] have observed a decrease 
of LVEDD from 55.54±7.95mm pre-operatively to 50.90±7.8mm post-
operatively and to 51.29±6.26mm. There was slight increase of LVEDD at 
follow up but it was still statistically different when compared to pre-operative 
measures. When observing the EF they have noticed a decrease from 
57.83±9.8% pre-operatively to 55.09±10.43% post-operatively and later 
complete restoration to 59.73±8.2% at follow up. 
In this study I have made a further insight into LV function and volume 
changes after both AVR and AVRep by comparing outcomes of patients 
undergoing AVR or AVRep for treatment of AR. Both groups have shown 
significant decrease in LV dimensions post-operatively with further decrease 
at early follow up appointments. The LV function in terms of LVEF has 
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decreased post-operatively, which was probably the consequence of acute 
correction of volume overload, but has normalized at early follow up in both 
groups. These results show us that durable AV repair in patients with AR with 
or without aortic root aneurysm is connected with beneficial outcome in terms 
of LV reverse remodeling and preserved LVEF immediately post-operatively 
and at early follow up.  
There are several limitations to this study that should be acknowledged. First, 
this is a retrospective and non-randomized study. There has also been quite a 
big loss due to follow up. Follow up data were difficult to collect due to lack of 
patients’ participation during follow up process and despite multiple attempts 
to reach patients through telephone some did not answer.  
In addition, the AVRep is a demanding procedure and the learning process is 
long. The surgeons in University Hospital Dubrava have only recently started 
performing the technique as described by Lansac et al. and despite good 
results until now, there is no doubt that there is room for improvement.  
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CONCLUSSION 
 
One could argue the idea of conservative approach to repairing the 
regurgitant valve rather than replacing it, as there is a significant risk of 
unsuccessful restoration of normal coaptation of leaflets and potential need 
for reoperation. The results of mitral valve repair have lead to mitral valve 
repair becoming superior to mitral valve replacement when dealing with mitral 
valve regurgitation. Even though AVR are known for technically easier, widely 
reproducible and applicable operations in comparison to AVRep techniques, 
the positive results of mitral valve repair have greatly influenced progress of 
AVRep techniques over the past 20 years.  
Theoretical benefits of native aortic valve repair rather than replacement with 
prosthesis and thus subjecting the patient to prosthesis related complications, 
such as thromboembolism, endocarditis and hemorrhage, have also been the 
reason for continuous improvements made in the field of AVRep techniques. 
Significant amount of knowledge has been gained over the past 20 years 
about the precise anatomy and physiology of AV and the importance of 
supporting structures for normal leaflet movements. Risk factors for potential 
failure of repair have been identified and various techniques have been 
proposed to approach them. This has led to good results in terms of freedom 
of reoperation and overall survival. 
It has been shown by this study that successful repair of AV leads to reverse 
remodeling of LV and improved LV function, which is comparable to LV 
remodeling seen after AVR.  
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